0      0

Making the Impossible, Possible: Partnerships and Purpose in Fighting the Pandemic

Feb 1, 2022 4:15pm ‐ Feb 1, 2022 4:45pm

Credits: None available.


Catalent, Inc. continues to play a strong partnership role, along with other CDMOs, in fighting the pandemic. The company’s expertise in implementing advanced pharmaceutical technologies uniquely positioned it to support biopharmaceutical companies seeking to manufacture COVID-19 vaccines and therapies. In 2021, Catalent produced over 1 billion COVID vaccines, while simultaneously manufacturing all of its other life-saving and -enhancing drugs for its customers and their patients. In this session, Catalent Chair and CEO John Chiminski will discuss key success factors, including how strong collaborations with both customers and supply chain partners, a strong focus on employee safety, and a shared purpose to defeat the pandemic, allowed the company to accelerate planned facilities expansions to help deliver vaccines in record time.



Credits: None available.

You must be logged in and own this session in order to post comments.